// App-Quantinova.ai

32 : C-reactive protein (CRP) as a prognostic biomarker in advanced non-small cell lung cancer treated with immune checkpoint inhibitors. Results from a multi-center international observational study

Researchers

Presenter

  • Abdul Rafeh Naqash

Principal Investigators

  • Alessio Cortellini

  • Emma Mi

  • Sanna Livanainen

  • Daria Gramenitskaya

  • James Clark

  • Kevin OBrien

  • Jussi Koivunen

  • Shravanti Macherla

  • Sweta Jonnalagadda

  • Shanker Polsani

  • Rahim Jiwani

  • Nitika Sharma

  • Chipman Stroud

  • Mahvish Muzaffar

  • Paul Walker

  • David Pinato

Medical Centers

  • National Cancer Institute, Silver Spring, MD

  • University of L'Aquila, L'Aquila, Italy.

  • Imperial College London, London, NY

  • University of Oulu, Oulu, Finland

  • Genentech, San Francisco, CA

  • Circulogene, Birmingham, AL

Locations

  • United States

  • Italy

  • United Kingdom

  • Finland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • N/A

Drug/Treatment

  • Interleukin

Outcome

  • N/A

Study Design

  • Observational

  • Multinational

  • Multicenteric

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved